This site uses cookies to improve your experience.

We use necessary cookies to make our site work. We would also like to set optional analytics cookies to help us improve our site by anonymously collecting and reporting information on how you use it. For more information on how these cookies work, please see our Cookie policy.

Vision Fund investment portfolio company Ventus Therapeutics's logo

Ventus Therapeutics is using computational tools to unlock elusive drug targets that address human disease.

Leadership
Marcelo Bigal
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas
Insights
Q&A
Marcelo Bigal: Always putting patients first

It comes down to everyone understanding Ventus Therapeutics’ core mission